ÂÜÀòÂÒÂ×

Dr. Bragg serves as Associate Professor of Pediatrics and Director of the NICU Follow-up Program and Cardiac Neurodevelopmental Program at a Level IV NICU in New York. As a neonatologist, she is passionate about optimizing neurodevelopmental outcomes through a collaborative, multidisciplinary approach to advancing children's health. Her research interests include rapid genomic sequencing in critically ill infants, assessing the impact of developmental programming on parental stress, and early identification of sensory processing disorders in high-risk infants. Through the accelerated research pathway of the American Board of Pediatrics, she completed a year of research fellowship in neonatal follow-up, during which time she received a grant to study the impact of plasticizers on very low birth weight infants. She has been designated as a Castle Connelly Top Doctor from 2019 to 2022 and has a wealth of experience in both leadership and administration. Dr. Bragg has held several roles on multiple medical committees addressing important hospital metrics. During the COVID-19 pandemic, she participated in a leadership course offered by Harvard Business Publishing that focused on successfully leading in a VUCA (Volatile, Uncertain, Complex, Ambiguous) world. She received her MD from New York University School of Medicine and completed her pediatric residency and perinatal neonatal fellowship at the Icahn School of Medicine at Mount Sinai in New York.